C.R. Bard (NYSE:BCR) closed its $262 million acquisition of Rochester Medical yesterday, giving former Rochester stockholders $20 per share and taking ROCM shares off the NASDAQ exchange.
Wall Street Beat
Kimberly-Clark hits 52-week high on news of medical device spinout
Kimberly-Clark (NYSE:KMB) said it’s planning to spin out its medical device and health products division as a separate public company, prompting investors to bid its stock up to a 52-week high yesterday and even higher today in pre-market trading.
UPDATE: Tandem Diabetes shares close 28% above IPO price
Shares of Tandem Diabetes Care (NSDQ:TNDM) closed up some more than 28% above their offering price today after the medical device company’s initial public offering debuted on the NASDAQ exchange.
BREAKING: Tandem Diabetes shares surge 30% above IPO price
Shares of Tandem Diabetes Care (NSDQ:TNDM) are up some 30% today after the medical device company’s initial public offering debuted on the NASDAQ exchange.
Tandem Diabetes prices $120M IPO
Tandem Diabetes Care is set to begin trading on the NASDAQ stock exchange today after pricing its initial public offering of 8 million shares at $15 each, the upper end of its initial range.
The amount the company actually raised could be higher than the $120 million pricing due to a 1.2 million-share over-allotment for the offering’s underwriters, which if exercised would push the raise to $138 million. Shares are expected to begin trading today under the TNDM symbol.
Rumor mill: Is Volcano ripe for a buyout? | MassDevice.com On Call
Derma Sciences losses widen, sales increase in Q3
Derma Sciences (NSDQ:DSCI) got a little bit of attention from Wall Street today, with shares up a modest 0.6% in late afternoon trading following release of the company’s Q3 earnings.
Mela Sciences takes new CEO from Johnson & Johnson, posts lackluster Q3
Listen to Mela Sciences’ Q3 2013 earnings call
Biosensors lowers guidance on weakness in stent market
Solta Medical gains on swing to Q3 black, layoffs, possible acquisition
Solta Medical (NSDQ:SLTM) shares gained today after the medical device company reported a swing to 3rd-quarter black ink and said it’s considering a sale.